ABSTRACT
Background: The diagnostic capability of 1,5-anhydro-D-glucitol (1,5-AG), a short-term glycaemic biomarker, for type 2 diabetes mellitus (T2DM), compared with glycated haemoglobin A1c (HbA1c), has yet to be documented among Nigerians.
Aim: Hence, the current study evaluated serum 1,5-AG’s diagnostic capability for T2DM in Nigerian patients in comparison to HbA1c
Methods: This cross-sectional study was conducted at the Rivers State University Teaching Hospital and included 150 individuals with T2DM,
recruited via simple random sampling. Laboratory parameters, including fasting plasma glucose, HbA1c, and serum 1,5-AG concentrations, were measured using standard methods. Descriptive statistics, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratios (PLR), negative likelihood ratios (NLR), diagnostic accuracy (DA), and receiver-operating characteristic (ROC) analysis, were used as statistical tools, at 95% confidence intervals and an alpha value of <0.05.
Results: HbA1c had an area under the curve (AUC) of 0.987 (95% CI: 0.975 0.999; p<0.001) with the best cut-off value of 6.40% with 88.4% sensitivity, 95.6% specificity, 98.4% PPV, 96.5% NPV, 89.7% DA, 89.7%, PLR of 20.1, and NLR of 0.12 for detecting T2DM. However, serum 1,5-AG also showed strong ROC performance with an AUC of 0.979 (95% CI: 0.966-0.993; p<0.001) at 61.8 µmol/L best cut-off value with 70.4% sensitivity, 93.8% specificity, 97.6% PPV, 95.4% NPV, 79.8% DA, PLR of 11.1, and NLR of 0.32 for detecting
T2DM.
Conclusion: The diagnostic capability of 1,5-AG for T2DM diagnosis approximated that of HbA1c. Hence, 1,5-AG could complement HbA1c as a
diagnostic tool in T2DM. However, further studies are recommended.
Keywords: Type 2 diabetes mellitus,1,5-Anhydro-D-Glucitol, 1,5-AG, FPG, HbA1c